Cargando…
SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?
BACKGROUND: Cancer metastasis is the main obstacle to increasing the lifespan of cancer patients. Epithelial-to-mesenchymal transition (EMT) plays a significant role in oncogenic processes, including tumor invasion, intravasation, and micrometastasis formation, and is especially critical for cancer...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244346/ https://www.ncbi.nlm.nih.gov/pubmed/32547193 http://dx.doi.org/10.2147/CMAR.S249754 |
_version_ | 1783537557761425408 |
---|---|
author | Sun, Li-rui Li, Si-yu Guo, Qiu-shi Zhou, Wei Zhang, Hong-mei |
author_facet | Sun, Li-rui Li, Si-yu Guo, Qiu-shi Zhou, Wei Zhang, Hong-mei |
author_sort | Sun, Li-rui |
collection | PubMed |
description | BACKGROUND: Cancer metastasis is the main obstacle to increasing the lifespan of cancer patients. Epithelial-to-mesenchymal transition (EMT) plays a significant role in oncogenic processes, including tumor invasion, intravasation, and micrometastasis formation, and is especially critical for cancer invasion and metastasis. The extracellular matrix (ECM) plays a crucial role in the occurrence of EMT corresponding to the change in adhesion between cells and matrices. CONCLUSION: SPOCK1 is a critical regulator of the ECM and mediates EMT in cancer cells. This suggests an important role for SPOCK1 in tumorigenesis, migration and invasion. SPOCK1 is a critical regulator of some processes involved in cancer progression, including cancer cell proliferation, apoptosis and migration. Herein, the functions of SPOCK1 in cancer progression are expounded, revealing the association between SPOCK1 and EMT in cancer metastasis. SPOCK1 is a positive downstream regulator of transforming growth factor-β, and SPOCK1-mediated EMT regulates invasion and metastasis through the Wnt/β-catenin pathway and PI3K/Akt signaling pathway. It is of significance that SPOCK1 may be an attractive prognostic biomarker and therapeutic target in cancer treatment. |
format | Online Article Text |
id | pubmed-7244346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-72443462020-06-15 SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? Sun, Li-rui Li, Si-yu Guo, Qiu-shi Zhou, Wei Zhang, Hong-mei Cancer Manag Res Review BACKGROUND: Cancer metastasis is the main obstacle to increasing the lifespan of cancer patients. Epithelial-to-mesenchymal transition (EMT) plays a significant role in oncogenic processes, including tumor invasion, intravasation, and micrometastasis formation, and is especially critical for cancer invasion and metastasis. The extracellular matrix (ECM) plays a crucial role in the occurrence of EMT corresponding to the change in adhesion between cells and matrices. CONCLUSION: SPOCK1 is a critical regulator of the ECM and mediates EMT in cancer cells. This suggests an important role for SPOCK1 in tumorigenesis, migration and invasion. SPOCK1 is a critical regulator of some processes involved in cancer progression, including cancer cell proliferation, apoptosis and migration. Herein, the functions of SPOCK1 in cancer progression are expounded, revealing the association between SPOCK1 and EMT in cancer metastasis. SPOCK1 is a positive downstream regulator of transforming growth factor-β, and SPOCK1-mediated EMT regulates invasion and metastasis through the Wnt/β-catenin pathway and PI3K/Akt signaling pathway. It is of significance that SPOCK1 may be an attractive prognostic biomarker and therapeutic target in cancer treatment. Dove 2020-05-18 /pmc/articles/PMC7244346/ /pubmed/32547193 http://dx.doi.org/10.2147/CMAR.S249754 Text en © 2020 Sun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Sun, Li-rui Li, Si-yu Guo, Qiu-shi Zhou, Wei Zhang, Hong-mei SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title | SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title_full | SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title_fullStr | SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title_full_unstemmed | SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title_short | SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy? |
title_sort | spock1 involvement in epithelial-to-mesenchymal transition: a new target in cancer therapy? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244346/ https://www.ncbi.nlm.nih.gov/pubmed/32547193 http://dx.doi.org/10.2147/CMAR.S249754 |
work_keys_str_mv | AT sunlirui spock1involvementinepithelialtomesenchymaltransitionanewtargetincancertherapy AT lisiyu spock1involvementinepithelialtomesenchymaltransitionanewtargetincancertherapy AT guoqiushi spock1involvementinepithelialtomesenchymaltransitionanewtargetincancertherapy AT zhouwei spock1involvementinepithelialtomesenchymaltransitionanewtargetincancertherapy AT zhanghongmei spock1involvementinepithelialtomesenchymaltransitionanewtargetincancertherapy |